(Mostly) Asia M&A: April 2020 Roundup
For the month of April, just six new deals were discussed on Smartkarma with an overall announced deal size of ~US$9.4bn. Clicking on the...
BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion
Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...
BBI Life: Privatisation Offer For DNA Synthesizer
Following a brief trading halt, BBI Life Sciences (1035 HK), the biggest supplier of DNA synthesis products in the PRC, announced a privatisation...
No more insights